HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(phenylthio-4-phenylamino)-2-nicotinic acid

inhibit prostaglandin synthesis by inhibiting prostaglandin synthase

Also Known As:

PTPAN; 3-Pyridinecarboxylic acid, 2-((4-(phenylthio)phenyl)amino)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Nicotinic Acids: 13
      - (phenylthio-4-phenylamino)-2-nicotinic acid: 1
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - (phenylthio-4-phenylamino)-2-nicotinic acid: 1

Experts

1.	Dong, Lei: 1 article (01/2022)
2.	Fang, Hongbao: 1 article (01/2022)
3.	Guo, Zijian: 1 article (01/2022)
4.	Han, Zhong: 1 article (01/2022)
5.	Shi, Xiangchao: 1 article (01/2022)
6.	Wang, Xiaoyong: 1 article (01/2022)
7.	Wang, Yanjun: 1 article (01/2022)
8.	Yuan, Hao: 1 article (01/2022)
9.	Zhu, Zhenzhu: 1 article (01/2022)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2022 - "Owing to its two-photon excitation property (λ = 825 nm), PtPAN may be suitable for the treatment of deep solid tumors."
2.	Hypoxia (Hypoxemia) 01/01/2022 - "PtPAN generates ROS efficiently under both normoxia and hypoxia. "